Publication details

Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMI

Authors

SELINGEROVÁ Iveta VALÍK Dalibor GESCHEIDTOVÁ Lenka ŠRÁMEK Vladimír CERMAKOVA Z. ZDRAŽILOVÁ DUBSKÁ Lenka

Year of publication 2021
Type Article in Periodical
Magazine / Source Journal of Medical Virology
MU Faculty or unit

Faculty of Medicine

Citation
Web https://onlinelibrary.wiley.com/doi/10.1002/jmv.26612
Doi http://dx.doi.org/10.1002/jmv.26612
Keywords anti- SARS- CoV- 2 IgG; anti- SARS- CoV- 2 IgM; CLIA; inter- assay batch variation; interpretative inconsistency
Description Plasma specimens from coronavirus disease 2019 patients were double-tested for anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies by two different batches of MAGLUMI 2019-nCov immunoglobulin M/immunoglobulin G (IgM/IgG) assays to evaluate IgM/IgG levels, qualitative interpretation, antibody kinetics, and linearity of diluted specimen. Here we show that (i) high-level IgM specimens need to be diluted with negative human plasma but not kit diluents and (ii) measured anti-SARS-CoV-2 IgM/IgG concentrations are substantially higher with later marketed immunoassay batch leading to (iii) the change of qualitative interpretation (positive vs. negative) in 12.3% of specimens measured for IgM, (iv) the informative time-course pattern of antibody production only when data from different immunoassay batches are not combined.

You are running an old browser version. We recommend updating your browser to its latest version.

More info